Virtual Medicinal Product (VMP)
-
Cytarabine 2g/20ml solution for injection vials
Name Details
Current Name
Cytarabine 2g/20ml solution for injection vials
|
Start Date
21-01-2009
|
End Date
|
Previous Name
Cytarabine 2g/20ml solution for infusion vials
|
Start Date
16-01-2009
|
End Date
20-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 20
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous, Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninfusion.intravenous, solutioninjection.intravenous, solutioninjection.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01BC01
BNF |
Current BNF
08010300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08010300
|
Start Date
09-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
36092311000001102 |
31-10-2018 |
|
326844004 |
22-08-2005 |
30-10-2018 |
4698811000001109 |
14-07-2003 |
21-08-2005 |
VMP Ingredients
VMP ingredients table
Cytarabine |
Based on Ingredient Substance |
|
100 mg |
1 ml |
Name
Cytarabine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Cytarabine
-
VMP
(Current) Cytarabine 2g/20ml solution for inje...
Virtual Medicinal Product Pack (VMPP) Information